currently clinical proton beams assumed fixed overall relative biological effectiveness rbe NUMBER known rbe increases depth bragg peak sobp NUMBER higher rbe NUMBER mm distal edge paganetti NUMBER technol cancer res treat NUMBER reach values vitro distal edge robertson et al NUMBER cancer NUMBER courdi et al NUMBER br j radiol NUMBER present fast method applying variable rbe correction linear energy transfer let dependent parameters based ratios suitable implementation treatment planning influence applying variable rbe correction clinical multiple beam proton dose plan presented treatment plan evaluated rbe weighted dose volume histograms dvhs calculation tumour control probability tcp normal tissue complication probability ntcp values variable rbe correction yields dvhs clinical target volumes ctvs primary advanced hypopharynx cancer subclinical disease lymph nodes slightly higher achieved multiplying absorbed dose rbe11 importantly rbe weighted dvh organ risk spinal cord considerably increased variable rbe spinal cord particular case located NUMBER mm planning target volume ptv receives low total doses ntcp values zero spite significant increase rbe weighted dvhs variable rbe high ntcp values normal tissue obtained applying variable rbe correction rbe variations tend smaller vivo systems vitro data human tissue rbe values scarce large interpreted showing upper limits possible effects utilizing variable rbe correction conclusion results obtained indicate significant difference introducing variable rbe compared applying generic rbe NUMBER suggesting worth considering correction clinical proton therapy planning especially risk organs located immediately target volume range modulated spread mid sobp NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER tissue specific non target study based uncertainties alpharef betaref